Eli Lilly to Sell Hit Weight-Loss Drugs Directly to Public

Eli Lilly & Co. launched a service to sell its weight-loss drugs directly to the public. That pits the company against startups such as Ro and Noom that have fed the frenzy over GLP-1 medications by making them easy to access online.

The drugmaker’s new digital health-care platform, dubbed LillyDirect, will help connect patients with obesity, diabetes and migraines to doctors who can prescribe medications including Mounjaro and Zepbound, the company said in a statement Thursday. It will also offer direct home delivery of certain drugs through third-party pharmacies, Lilly has partnered with closely-held Form Health Inc., a virtual ...